KIMBERLY C PITTMAN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care ATHENS, GA NPI 1487780342

General Payments — all program years on this page

$4,750.43

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 232
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $493.84 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $493.8422

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $1,150.0560
2022 $1,777.0988
2023 $1,329.4562
2024 $493.8422

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078520812 Janssen Biotech, Inc. $19.26 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078521388 Janssen Biotech, Inc. $19.27 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078521809 Janssen Biotech, Inc. $19.66 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087255243 Novartis Pharmaceuticals Corporation $26.11 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087255255 Novartis Pharmaceuticals Corporation $31.03 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094003549 Alexion Pharmaceuticals, Inc. $25.33 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101084501 Celgene Corporation $24.13 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108022704 ABBVIE INC. $16.13 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108022706 ABBVIE INC. $16.69 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116396292 GlaxoSmithKline, LLC. $14.49 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116562912 GlaxoSmithKline, LLC. $18.03 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127052243 Kyowa Kirin, Inc. $16.62 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133168402 Genentech USA, Inc. $18.51 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135761138 Lilly USA, LLC $20.70 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142968669 Stemline Therapeutics Inc. $32.91 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142968671 Stemline Therapeutics Inc. $31.45 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142968673 Stemline Therapeutics Inc. $20.25 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142968675 Stemline Therapeutics Inc. $14.89 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144982014 Takeda Pharmaceuticals U.S.A., Inc. $29.78 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147107284 Acrotech Biopharma Inc. $15.99 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147279226 Coherus Biosciences Inc. $24.80 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151306196 JAZZ PHARMACEUTICALS INC. $37.81 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.